Overview

Gender

male

Investor Type

Angel

Matt is responsible for strategy, marketing, alliances and business development at Veeva Systems. In 2007, Matt was named to the PharmaVOICE 100 which recognizes the 100 most influential people in the life sciences industry.

Before founding Veeva, Matt held various executive roles at small healthcare technology companies in product management, marketing and business development.

Prior to his small company forays, Matt was the General Manager of the Pharmaceuticals & Biotechnology division at Siebel Systems, which has since been acquired by Oracle. During his time at Siebel, Matt was responsible for building this global division which grew from its inception to over $140 million under his leadership capturing greater than 80% market share in the pharma CRM and clinical trial management (CTM) markets. At one point, nearly half of all pharma sales reps on earth used the products created during his tenure at Siebel, though that is rapidly changing these days.

Matt currently serves on the NSD Board of Directors at the National Association of Independent Schools (NAIS) and is on the Advisory Board at Crossix, an innovator in the healthcare analytics arena. Matt received his MBA from the Harvard Business School, with honors, and his B.A. in Economics from Yale University, cum laude.